The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

The Oncology Institute, Inc.NASDAQ: TOI

Retained Earnings · Q1 FY2026 · quarter ended Mar 2026

Retained earnings remains negative

Q1 FY2026 retained earnings was -$273.91M, compared with -$230.4M a year earlier.

Context

  • Retained earnings amounted to 162.8% of total assets at the end of Q1 FY2026, up 22.3 pp from a year earlier.
  • Retained earnings grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether retained earnings keeps falling in the next quarterly balance sheet after a -18.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$273.91M-0.9% QoQ
Last fiscal yearDec 2025
-$271.42M-28.7% YoY
Year agoMar 2025
-$230.4M-18.9% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-18.9%——
1 year-28.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2025
(271.42M) USD
Year-over-year change
-28.7%

Retained Earnings vs competitors

How TOI compares with its peers on the latest reported figures

  • Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -18.9% is the 4th highest of 10, against a peer median of -23.0%.
  • Retained earnings amounts to 162.8% of total assets for TOI, versus a peer median of 128.2%.
TOI Competitors
Retained Earnings for TOI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CCRNCross Country Healthcare, Inc.Mar 2026$118.94M USD-45.3%-9.4%26.4%
AUNAAuna S.A.Mar 2026-PEN 186.07M PEN+21.9%—2.4%
CBLLCeriBell, Inc.Mar 2026-$240.09M USD-33.6%—134.8%
TMCITreace Medical Concepts, Inc.Mar 2026-$266.95M USD-29.6%—145.0%
TOIThe Oncology Institute, Inc.Mar 2026-$273.91M USD-18.9%—162.8%
KIDSOrthoPediatrics Corp.Mar 2026-$285.9M USD-16.1%—56.9%
SNDASonida Senior Living, Inc.Mar 2026-$532.23M USD-23.0%—20.3%
EOLSEvolus, Inc.Mar 2026-$671.71M USD-6.9%—304.4%
AUTLAutolus Therapeutics plcMar 2026-$1.46B USD-24.7%—276.7%
AGLAgilon Health, Inc.Mar 2026-$1.93B USD-22.5%—128.2%
Peer median (excluding TOI) —-23.0%-9.4%128.2%

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents114.3M14.01M33.49M49.67M33.57M
Short-term Investments059.8M49.37M00
Net Receivables21.24M40.43M42.91M48.68M59.32M
Inventory6.44M9.26M13.68M10.04M16.88M
Other Current Assets875K004.03M2.99M
Total Current Assets154.06M130.42M143.49M112.42M112.75M
Property, Plant & Equipment (Net)4.19M33.04M40.05M37.67M33.06M
Goodwill26.63M21.42M7.23M7.23M7.23M
Intangible Assets18.25M17.96M17.9M14.81M11.02M
Long-term Investments(371K)58.35M000
Tax Assets371K0000
Other Non-current Assets320K477K561K589K606K
Total Non-current Assets49.38M131.25M65.75M60.3M51.91M
Total Assets203.44M261.67M209.24M172.72M164.66M
Account Payables15.56M9.37M14.43M24.32M43.17M
Short-term Debt183K0000
Tax Payables132K255K000
Deferred Revenue592K1.14M545K4.7M2.28M
Other Current Liabilities10.14M9.35M11.33M10.35M13.15M
Total Current Liabilities29.8M29.72M34.79M52.22M70.96M
Long-term Debt080.62M86.83M93.13M77.4M
Deferred Tax Liabilities371K108K32K32K0
Deferred Revenue (Non-current)00000
Other Non-current Liabilities69.11M5.98M4.08M527K12.88M
Total Non-current Liabilities69.48M108.77M117.43M116.91M109.41M
Total Liabilities99.28M138.49M152.22M169.13M180.38M
Common Stock7K7K8K8K10K
Retained Earnings(63.23M)(63.08M)(146.15M)(210.81M)(271.42M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity104.16M123.18M57.03M3.59M(15.72M)
Total Debt183K108.18M119.68M123.15M103.69M
Net Debt(114.12M)94.17M86.19M73.48M70.12M

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.